Application of carbohydrate antigen 19-9 and bone metabolic marker to monitor the chemotherapy of colorectal cancer patients with bone metastases
HE Yan
Application of carbohydrate antigen 19-9 and bone metabolic marker to monitor the chemotherapy of colorectal cancer patients with bone metastases
| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |